ZA200711163B - Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue - Google Patents

Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue

Info

Publication number
ZA200711163B
ZA200711163B ZA200711163A ZA200711163A ZA200711163B ZA 200711163 B ZA200711163 B ZA 200711163B ZA 200711163 A ZA200711163 A ZA 200711163A ZA 200711163 A ZA200711163 A ZA 200711163A ZA 200711163 B ZA200711163 B ZA 200711163B
Authority
ZA
South Africa
Prior art keywords
treatment
coeliac disease
madcam antibodies
tropical sprue
sprue
Prior art date
Application number
ZA200711163A
Other languages
English (en)
Inventor
Burgess Gary Craig
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of ZA200711163B publication Critical patent/ZA200711163B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
ZA200711163A 2005-07-08 2007-12-20 Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue ZA200711163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69745405P 2005-07-08 2005-07-08

Publications (1)

Publication Number Publication Date
ZA200711163B true ZA200711163B (en) 2008-10-29

Family

ID=37491744

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200711163A ZA200711163B (en) 2005-07-08 2007-12-20 Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue

Country Status (15)

Country Link
US (1) US20100119517A1 (xx)
EP (1) EP1904103A2 (xx)
JP (1) JP2007016030A (xx)
KR (1) KR20080017088A (xx)
CN (1) CN101227923A (xx)
AR (1) AR055072A1 (xx)
AU (1) AU2006268045A1 (xx)
BR (1) BRPI0612645A2 (xx)
CA (1) CA2613017A1 (xx)
IL (1) IL188318A0 (xx)
MX (1) MX2008000129A (xx)
RU (1) RU2007149268A (xx)
TW (1) TW200740845A (xx)
WO (1) WO2007007145A2 (xx)
ZA (1) ZA200711163B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2006003689A0 (en) 2004-01-09 2006-08-31 Pfizer Antibodies to MAdCAM
BRPI0608855A2 (pt) * 2005-03-08 2010-02-02 Pharmacia & Upjohn Co Llc composições de anticorpo anti - madcam processo para a preparação das mesmas e uso de anticorpo anti - madcam
CA2916283A1 (en) 2015-01-09 2016-07-09 Pfizer Inc. Dosage regimen for madcam antagonists
AR112336A1 (es) 2017-07-14 2019-10-16 Pfizer ANTICUERPOS CONTRA MAdCAM

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551593B1 (en) * 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US7803904B2 (en) * 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof

Also Published As

Publication number Publication date
IL188318A0 (en) 2008-04-13
AR055072A1 (es) 2007-08-01
EP1904103A2 (en) 2008-04-02
WO2007007145A2 (en) 2007-01-18
MX2008000129A (es) 2008-03-18
TW200740845A (en) 2007-11-01
CN101227923A (zh) 2008-07-23
CA2613017A1 (en) 2007-01-18
BRPI0612645A2 (pt) 2010-11-23
US20100119517A1 (en) 2010-05-13
KR20080017088A (ko) 2008-02-25
RU2007149268A (ru) 2009-07-10
AU2006268045A1 (en) 2007-01-18
JP2007016030A (ja) 2007-01-25
WO2007007145A3 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
GB2429013C (en) Peptides for treatment and diagnosis of autoimmunedisease
EP1814909A4 (en) USE OF AIMP2DX2 FOR THE DIAGNOSIS AND TREATMENT OF CANCER
HRP20150175T1 (xx) Sredstva za i postupci lijeäśenja tumorskih bolesti
EP1951892A4 (en) ANTIBODY TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
EP1928453A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RENAL DISEASES
EP1804661A4 (en) SYSTEM FOR INTEGRATED ILLNESS DIAGNOSIS AND TREATMENT
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
IL178815A0 (en) The treatment of respiratory disease
EP2001503A4 (en) DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER
EP1812077A4 (en) MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING A FIBROSIS-ASSOCIATED DISEASE
GB0410399D0 (en) The treatment of respiratory disease
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
GB2427361B (en) Treatment device for the human body
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
EP1773882A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH SIGLEC-6
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
ZA200711163B (en) Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1797430A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
IL191887A0 (en) Method for the diagnosis and treatment of cardiovascular diseases
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
SG126063A1 (en) Methods for the treatment of insulin resistance and disease states characterized by insulin resistance